Related Experiment Video
Updated: Jun 6, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
[Expression and role of amyloid precrusor protein gene in acute myeloid leukemia]
Wei Wang1, Fan-Yi Meng, Zou-Fang Huang
1Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Objective:
To investigate the expression of amyloid precursor protein (APP) gene in acute myeloid leukemia (AML) and its biological behaviour in AML cells.
Methods:
The expressions of APP mRNA in 85 AML and 20 nonmalignant hematological diseases patients (as control) were measured by real-time PCR. The expression of APP in AML cell lines was also examined by real-time PCR and Western blot and the results were compared with those in their original subtypes. Small interfering RNAs (siRNAs) targeting APP gene were synthesized and transfected into HL-60 cell by lipofectamine 2000 for 24 h, 48h and 72 h. Cell growth was measured by trypan blue dye exclusion and MTT, differentiation by Wright-Giemsa staining, cell cycle by PI/RNase staining, apoptosis by Annexin V/PI and Hoechst33342 staining. Apoptosis-related protein NF-κB, bcl-2 and Caspase-3 were detected by Western blot after siRNAs transfection for 48 h. Sensitivity to adriamycin was measured by MTT.
Results:
The expression of APP mRNA among AML subtypes differed significantly (P = 0.019), the highest expression subtype was M(2) with t(8;21) (median 0.1080), followed in order by AML-undefined (0.0467), M(3) (0.0266), M(2a) (0.0221), M(4a) (0.0167), M(5b) (0.0151), and M(4b) (0.0025). APP expression had no significant effect on AML clinical characteristics excepting for subtypes. The expression of APP in Kasumi-1 cells was significantly higher than that of U937 cells (P < 0.05), which was in agreement with APP expression in their original AML subtypes. After siRNAs transfection for 24 h, 48 h, and 72 h, no significant difference in proliferation, differentiation, apoptosis, cell cycle and sensitivity to adriamycin was detected between interfering group and control groups (P > 0.05).
Conclusions:
The APP mRNA expression was highest in M(2) with t(8;21) and lowest in M(5b). Down-regulation of APP expression has no significant effects on biological behaviour of HL-60 cells.
Insights
Amyloid precursor protein (APP) gene expression varies significantly across acute myeloid leukemia (AML) subtypes, being highest in M(2) with t(8;21). However, reducing APP expression did not impact the biological behavior of HL-60 AML cells.
Area of Science:
- Hematology
- Molecular Biology
- Oncology
Background:
- Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy.
- Amyloid precursor protein (APP) is implicated in various cellular processes.
- Understanding gene expression patterns in AML is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the expression levels of the amyloid precursor protein (APP) gene in acute myeloid leukemia (AML).
- To analyze the correlation between APP gene expression and the biological behavior of AML cells.
Main Methods:
- Real-time PCR and Western blot were used to measure APP mRNA and protein expression in AML patient samples and cell lines.
- Small interfering RNAs (siRNAs) were employed to down-regulate APP expression in HL-60 cells.
- Cell proliferation, differentiation, cell cycle, apoptosis, and drug sensitivity were assessed after APP knockdown.
Main Results:
- APP mRNA expression levels varied significantly among different AML subtypes, with the highest expression observed in M(2) with t(8;21).
- APP expression in AML cell lines (Kasumi-1 vs. U937) correlated with their respective subtype expression.
- Down-regulation of APP using siRNAs did not significantly alter proliferation, differentiation, cell cycle, apoptosis, or adriamycin sensitivity in HL-60 cells.
Conclusions:
- APP mRNA expression is differentially regulated across AML subtypes.
- Targeted down-regulation of APP does not appear to influence the fundamental biological characteristics of HL-60 AML cells.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Abnormal Proliferation
Leaky Scanning
Differentiation of Common Myeloid Progenitor Cells
RNA Splicing
The Ras Gene
Ras is a superfamily...

